Volume 24, Number 1—January 2018
Research
Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China
Table
Variable | Donor | Packed red blood cell recipient (index patient) | Platelet recipient | Plasma recipient |
---|---|---|---|---|
Underlying disease |
No history of disease, no recent travel to JEV-endemic regions outside Hong Kong; resides in JEV-endemic area Tin Shui Wai, Yuen Long |
End-stage chronic obstructive pulmonary disease with lung transplantation, May 10 |
Acute myeloid leukemia post induction chemotherapy with cytarabine and daunorubicin |
Intracranial hemorrhage |
Blood donation or transfusion type, date |
Blood donation, May 29 |
Packed red blood cell transfusion, June 22 |
Platelet transfusion, June 2 |
Plasma transfusion, June 20 |
Pretransfusion IgM serology result, date |
Specimen not available |
Serum negative, May 31 |
Serum negative, May 25 |
Specimen not available |
Posttransfusion IgM serology result, date |
Serum positive, July 22 |
CSF positive, July 11; serum positive, July 15 and 18 |
Serum positive, July 5 and 22 |
Specimen not available |
JEV nucleic acid test, specimen type and result, date |
Positive archived blood specimen |
Positive blood sample, June 26 and 28; positive bronchoalveolar lavage, July 10 |
Negative plasma sample, July 22; negative urine sample, July 25 |
Specimen not available |
Clinical symptoms |
Asymptomatic |
Fever and rash July 6 (14 d after transfusion), followed by decreased consciousness and myoclonic jerks; MRI showed typical appearance of T2 hyperintensity of bilateral thalami, substantia nigra, and medial temporal lobes |
Asymptomatic |
Unknown |
Outcome | Full recovery | Died October 1, 2017 | Full recovery | Died from respiratory failure 14 d after transfusion |
*CSF, cerebrospinal fluid; JEV, Japanese encephalitis virus; MRI, magnetic resonance imaging.
1These authors contributed equally to this article.
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.